Effect of PTSD treatment on cardiovascular reactivity during trauma memory recall and correspondence with symptom improvement.

ABSTRACTBackground: Prior research has shown PTSD treatment leads to reductions in cardiovascular reactivity during trauma recall, but the extent to which such reductions are associated with changes in PTSD symptoms is less clear. Moreover, such relationships have not been investigated in a cognitively focused PTSD treatment.Objective: To examine changes in cardiovascular reactivity to the trauma memory in patients receiving cognitive processing therapy (CPT), CPT with a written trauma account, and a written account only condition. We also examined the association of such changes with symptom improvement.Method: 118 women with PTSD secondary to interpersonal violence completed pre- and post-treatment assessments of PTSD symptoms and cardiovascular reactivity during a script-driven imagery task.Results: Results indicated a significant but modest reduction in cardiovascular reactivity in CPT conditions. Changes in cardiovascular reactivity and reexperiencing symptoms were significantly associated among the whole sample. Among individuals with the greatest reactivity to the trauma memory at pretreatment, associations were also seen with changes in total PTSD, numbing, and trauma-related guilt.Conclusions: Results indicate that previous findings on the effect of PTSD treatment on cardiovascular reactivity during trauma recall extend to cognitively oriented treatment. Baseline cardiovascular reactivity may influence the extent to which reductions in PTSD symptoms and reactivity during trauma recall are related.

Cognitive Processing Therapy leads to reduced heart rate reactivity when recalling a trauma memory.Decreases in heart rate reactivity are associated with reduced reexperiencing symptoms.Changes in heart rate reactivity and PTSD symptoms are more closely related among patients with greater pretreatment reactivity.

Instrumentos predictores del éxito en la protetización de pacientes con amputaciones unilaterales mayores de miembro inferior / Objective measurement tools that predict success in the fitting of major unilateral lower limb amputations patients

El perfil del paciente que más frecuentemente sufre amputaciones de miembro inferior suele ser uno de edad avanzada y alta comorbilidad. Los médicos rehabilitadores precisamos en la valoración de estos pacientes de herramientas objetivas que predigan los resultados de los programas de protetización para aumentar la seguridad del paciente y eficiencia de los programas de rehabilitación protésica. Dada la necesidad de actualizar el conocimiento científico en este campo hemos realizado una revisión de la literatura con el objetivo de definir una propuesta de herramientas que faciliten la toma de decisiones en la indicación de rehabilitación protésica en estos pacientes. Para la realización de este trabajo se ha realizado una estrategia de búsqueda bibliográfica utilizando las bases de datos científicas PubMed, Web of Science, Scopus y Cochrane Library. La calidad de los artículos seleccionados se ha valorado según las herramientas propuestas por CASPe.(AU)

The profile of the patient who most frequently suffers lower limb amputations is usually an elderly patient with high comorbidity. Physiatrists need objective tools in the assessment of these patients that predict the results of prosthetic programs to increase patient safety and efficiency of prosthetic rehabilitation programs. Given the need to update scientific knowledge in this field, we have carried out a review of the literature with the aim of defining a proposal for tools that facilitate decision-making in the indication of prosthetic rehabilitation in these patients. A bibliographic search strategy has been carried out using the scientific databases PubMed, Web of Science, Scopus and Cochrane Library. The quality of the selected articles has been assessed according to the tools proposed by CASPe.(AU)

Influencia del índice de masa corporal en las técnicas de reproducción asistida / Influence of Body Mass Index on Assisted Reproductive Techniques

Objetivo: Analizar la relación entre el índice de Masa Corporal en mujeres y los resultados obtenidos en las técnicas de reproducción asistida. Método: Se llevó a cabo un diseño no experimental, transversal, descriptivo y correlacional, mediante un análisis de datos secundarios en varias clínicas de reproducción asistida en España. Se analizaron 3.273 historias clínicas de mujeres sometidas a fecundación in vitro entre 2015-2018. Se recogieron datos de filiación e inicio del tratamiento, datos antropométricos, antecedentes personales, enfermedades actuales, esterilidad primaria, esterilidad secundaria, así como los parámetros referentes a los resultados tras tratamiento de reproducción asistida. El análisis estadístico se realizó mediante el software SPSS-V19.0. Resultados: 798 mujeres (24,42%) tenían un IMC ≥25. Las mujeres con sobrepeso consiguieron un menor número de ovocitos recuperados y fecundados, así como menor número de embriones obtenidos. Las mujeres con peso normal consiguieron un menor número de óvulos maduros y las mujeres con bajo peso presentaron una menor tasa de fecundación. Conclusiones: Se ha encontrado que los resultados obtenidos en las técnicas de reproducción asistida tienen relación con el índice de Masa Corporal de las mujeres. (AU)

Objective: To analyze the relationship between the Body Mass Index in women and the results obtained in assisted reproductive techniques. Methods: A non-experimental, cross-sectional, descriptive and correlational design was carried out through an analysis of secondary data in several assisted reproduction clinics from Spain. 3,273 medical records of women undergoing In Vitro Fertilization between 2015 and 2018 were analyzed. Data on affiliation and treatment initiation, anthropometric data, personal history, current diseases, primary and secondary infertility, as well as the reference parameters to the results after the assisted reproduction treatment were collected. The statistical analysis was performed using SPSS v19.0 software. Results: A total of 798 women (24.42%) had a BMI values ≥ 25. The overweight women achieved a lower number of oocytes retrieved and fertilized, as well as fewer embryos obtained. The women with normal weight achieved a lower number of mature oocytes and those with low weight had a lower fertilization rate. Conclusions: It has been found that the results obtained in assisted reproductive techniques are related to women's Body Mass Index. (AU)

[Objective measurement tools that predict success in the fitting of major unilateral lower limb amputations patients]. / Instrumentos predictores del éxito en la protetización de pacientes con amputaciones unilaterales mayores de miembro inferior.

The profile of the patient who most frequently suffers lower limb amputations is usually an elderly patient with high comorbidity. Physiatrists need objective tools in the assessment of these patients that predict the results of prosthetic programs to increase patient safety and efficiency of prosthetic rehabilitation programs. Given the need to update scientific knowledge in this field, we have carried out a review of the literature with the aim of defining a proposal for tools that facilitate decision-making in the indication of prosthetic rehabilitation in these patients. A bibliographic search strategy has been carried out using the scientific databases PubMed, Web of Science, Scopus and Cochrane Library. The quality of the selected articles has been assessed according to the tools proposed by CASPe.

A systematic review on extensively drug-resistant tuberculosis from 2009 to 2020: special emphases on treatment outcomes / Una revisión sistemática sobre la tuberculosis extremadamente resistente de 2009 a 2020: énfasis especial sobre los resultados del tratamiento

Objectives: Extensively drug-resistant tuberculosis (XDR-TB) has raised a great threat to human health globally, especially in developing countries. The objective of the present study is to collate and contrast the proportions of treatment outcome in the previously published XDR-TB articles. Material and methods: By considering inclusion criteria and search engines, a total of 22 articles were enrolled. Results. Our findings revealed that the overall favorable treatment outcome was 24.04%. From the cohort of enrolled studies 19.76% (397) and 43.35% (871) patients were cured and died respectively. In 90.9% of enrolled articles, the investigators performed drug-susceptibility testing at the baseline. The overall treatment outcome was improved by the use of new drugs (linezolid, bedaquiline, ciprofloxacin, clofazimine) in the treatment regimen of XDR-TB showing linezolid and bedaquiline better results i.e. 59.44 and 78.88%, respectively. Moreover, use of antiretroviral treatment in XDR-TB patients with HIV infection have not shown any significant difference in the treatment outcome. Conclusions: XDR-TB treatment success can be achieved by implying standardized definitions, upgraded diagnostic procedures, and novel drugs. (AU)

Objetivos: La tuberculosis extremadamente resistente (XDR-TB) ha planteado una gran amenaza para la salud humana a nivel mundial, especialmente en los países en desarrollo. El objetivo del estudio es recopilar y contrastar las proporciones del resultado del tratamiento en los artículos de XDR-TB publicados.Material y métodos: Teniendo en cuenta los criterios de inclusión y los motores de búsqueda un total de 22 artículos fueron incluidos. Resultados. Nuestros hallazgos revelaron que el resultado total del tratamiento favorable fue del 24,04%. De la cohorte de estudios inscritos, el 19,76% (397) y el 43,35% (871) de los pacientes se curaron y murieron, respectivamente. En el 90,9% de los artículos, los investigadores realizaron pruebas de sensibilidad. El resultado total del tratamiento mejoró mediante el uso de nuevos medicamentos (linezolid, bedaquilina, ciprofloxacino, clofazimina) en el régimen de tratamiento de XDR-TB, mostrando linezolid y bedaquilina los mejores resultados, 59,44 y 78,88%, respectivamente. Además, el uso del tratamiento antirretroviral en pacientes con XDR-TB y con infección por VIH no mostró ninguna diferencia significativa en el resultado del tratamiento. Conclusiones: El éxito del tratamiento de la XDR-TB se puede lograr implicando definiciones estandarizadas, procedimientos de diagnóstico mejorados y nuevos medicamentos. (AU)

Imatinib en leucemia mieloide crónica: resultados en práctica clínica habitual / Imatinib in chronic myeloid leukemia: outcomes in routine clinical practice

Objetivos: Imatinib cambió el paradigma de la leucemia mieloide crónica (LMC), tras lograr en los ensayos clínicos frente a interferón mejor tasa de respuestas y supervivencia libre de progresión, con un aceptable perfil de toxicidad. El objetivo del presente estudio fue evaluar la efectividad, seguridad y adherencia de imatinib en LMC en la práctica clínica habitual.Métodos: Estudio observacional retrospectivo en pacientes con LMC en fase crónica tratados con imatinib. Objetivos principales: respuesta completa hematológica (RCH), respuesta completa citogenética (RCyC), respuesta mayor molecular (RMM), adherencia (ADH) y efectos adversos (EA). Las tasas de respuesta fueron definidas según criterios de The European LeukemiaNet y la ADH como dosis totales dispensadas x 100/dosis totales prescritas. Se consideraron adherentes aquellos pacientes con ADH ≥85%. Variables secundarias: supervivencia libre de progresión (SLP) y global (SG).Resultados: Se incluyeron un total de 39 pacientes. Tasas de respuesta: RCH 100%, RCyC 84,6% y RMM 66,7%. La ADH media al tratamiento fue de 94,9%, con un 92,3% de pacientes adherentes. Las tasas de SLP y SG estimadas a los 8 años fueron 94,4% (IC95%: 86,9-100,0) y 94,4% (IC95%: 87,3-100,0) respectivamente. EA no hematológicos más frecuentes: edemas (53,8%), dolor músculo-esquelético (43,6%) y calambres (38,5%). Se encontró neutropenia y trombocitopenia grado 3-4 en el 10,3% y 5,1% de los pacientes respectivamente.Conclusiones: Imatinib induce respuestas duraderas en una notable proporción de pacientes, consiguiendo mantener la enfermedad bajo control. Este estudio confirma el beneficio de imatinib en práctica clínica habitual. El perfil de seguridad es consistente con los resultados obtenidos en estudios previos. (AU)

Objectives: Imatinib changed the treatment paradigm of chronic myeloid leukemia (CML) after yielding better response rates and progression free survival than interferon-α, with an acceptable safety profile. The aim of this study was to evaluate the effectiveness, safety and adherence of imatinib in the treatment of CML in clinical practice.Methods: Retrospective study carried out in patients with CML in chronic phase treated with imatinib. Primary endpoints: complete hematological response (CHR), complete cytogenetic response (CCyR), major molecular response (MMR), treatment adherence (ADH) and adverse events (AE). Response rates were defined according to the criteria of The European LeukemiaNet and ADH was estimated as number of dosage units dispensed x 100/ number of dosage units prescribed. Patients were adherent if their ADH was ≥85%. Secondary endpoints: progression free survival (PFS) and overall survival (OS).Results: 39 patients were included. Response rates: CHR 100% (39/39); CCyR 84.6% (33/39); and MMR 66.7% (26/39). The mean ADH was 94.9% (59.0%-100%), with a 92.3% of patients considered adherents. PFS and OS rates estimated at 8 years were: 94.4% (95% CI: 86.9-100.0) and 94.4% (95% CI: 87.3-100.0), respectively. Most frequent non-hematological AE: edema 53.8% (21/39), musculoskeletal pain 43.6% (17/39) and muscle cramps 38.5% (15/39). Grade 3-4 neutropenia and thrombocytopenia were found in 10.3% (4/39) and 5.1% (2/39) of patients, respectively.Conclusions: Imatinib induced sustainable responses in a remarkable proportion of real world patients, managing to keep the disease under control. This study confirms the benefits of imatinib in clinical practice. The safety profile was consistent with earlier reports. (AU)

Evaluación de la relación exposición-respuestade cetuximab en pacientes con cáncer colorrectal metastásico y cáncer de cabeza y cuello / Assessment of exposure-response relationship for cetuximab in patients with metastatic colorectal cancer and head and neck cancer

Objetivo: Evaluar, en condiciones de vida real, la relación entre lasconcentraciones valle en estado estacionario de cetuximab y el control dela enfermedad, así como buscar la relación entre estas concentraciones y lasupervivencia. Además, estudiar si existe una concentración límite que sepueda asociar con la probabilidad de beneficio clínico.Método: Estudio observacional prospectivo llevado a cabo en pacientescon cáncer colorrectal metastásico o cáncer de cabeza y cuello entratamiento con cetuximab. Se realizó un análisis de regresión de ecuacionesde estimación generalizadas para evaluar la asociación entre laconcentración valle en estado estacionario de cetuximab y la respuesta altratamiento (progresión o beneficio clínico). Mediante modelos de riesgosproporcionales de Cox, se evaluó la asociación entre la mediana de concentracionesvalle en estado estacionario de cetuximab en cada pacienteo la última medida con la supervivencia global y la supervivencia librede progresión, en cada una de las patologías. Asimismo, se buscó unpunto de corte óptimo a través del área bajo la curva de característicasoperativas del receptor. Resultados: Se analizaron 30 muestras de 16 pacientes. La concentraciónvalle en estado estacionario mediana fue 26,86 mg/l y se encontróuna gran variabilidad inter e intraindividual (desviación estándar de 32,4 y16,9 mg/l, respectivamente). Se observó una asociación positiva entre laconcentración valle en estado estacionario y el beneficio clínico (odds ratio1,24; intervalo de confianza del 95%: 0,95-1,63; p = 0,113), aunque noalcanzó significación estadística debido a la baja potencia.

Objective: There is limited scientific evidence on the cetuximab exposure-response relationship and no concentration threshold has been associatedwith optimal disease control. The aims were to assess, in a real-lifesetting, the relationship between steady state cetuximab concentrations(Ctrough, SS) and disease control.Method: A prospective observational study in patients with metastaticcolorectal cancer or head and neck cancer treated with cetuximab. Steadystate trough concentrations were compared with the results of radiologicalassessment of response (progression or clinical benefit). Generalizedestimating equations analysis was performed. To test the association betweensteady state concentrations and overall survival and progression-freesurvival, Cox proportional hazard models were developed. An optimalcut-off point was searched using the area under the receiver operatingcharacteristic curve.Results: A total of 30 steady state cetuximab concentrations from16 patients were analysed. Median Ctrough, SS was 26.86 mg/L andthere was marked inter- and intraindividual variability (standard deviation 32.4 mg/L and 16.9 mg/L, respectively). A positive associationwas found between cetuximab Ctrough, SS and clinical benefit (odds ratio1.24, 95% confidence interval: 0.95-1.63, p = 0.113), although withoutreaching statistical significance. The area under the receiver operatingcharacteristic curve (n = 30) had moderate discrimination power (0.71;95% confidence interval 0.49‑0.93), and the empirical optimal cutoffpoint was 19.12 mg/L. However, no association was observed betweencetuximab Ctrough, SS and survival in metastatic colorectal cancer or neckcancer patients.

Identación escleral y retinopexia neumática / Scleral buckling and neumatic retinopexy

Objetivo: Determinar los resultados de la técnica quirúrgica de identación escleral y la de retinopexia neumática en el desprendimiento regmatógeno de retina. Métodos: Se realizó un estudio descriptivo, longitudinal y prospectivo en pacientes operados con la técnica de identación escleral y la de retinopexia neumática en el Centro Oftalmológico de Villa Clara entre junio de 2019 y diciembre de 2020. Resultados: Los hombres fueron los más afectados y la edad media fue de 57,5 años. En el 72,7 por ciento la rotura causante del desprendimiento fueron los desgarros en herradura. La media del tiempo de evolución de la enfermedad fue de 7,2 días y el 77,3 por ciento de los ojos presentaba mácula desprendida al momento del diagnóstico. El 68,2 por ciento tuvo una agudeza visual mejor corregida preoperatoria < 20/200. Los pacientes con mácula desprendida preoperatoria alcanzaron como media una agudeza visual final de 0,4 ± 0,3 (desviación estándar). En el 86,4 y el 77,3 por ciento de los ojos se lograron buenos resultados anatómicos y funcionales finales. Las membranas epirretinales se presentaron como complicación posoperatoria en ambas técnicas quirúrgicas y el líquido subretinal residual solo en la retinopexia neumática. Conclusiones: El desprendimiento regmatógeno de retina se presenta con pobre agudeza visual preoperatoria. Con ambas técnicas quirúrgicas, en pacientes con ninguna o mínima vitreorretinopatía proliferativa, se logran buenos resultados anatómicos y funcionales.

Objective: Determine the results of the surgical technique of scleral buckling and neumatic retinopexy in rhegmatogenous retinal detachment. Methods: A prospective longitudinal descriptive study was conduced of patients undergoing scleral buckling and neumatic retinopexy at Villa Clara Ophthalmology Center from June 2019 to December 2020. Results: Male gender prevailed; mean age was 57.5 years. In 72.7 percent of the cases the retinal break causing the detachment was a U-shaped tear. Mean time of evolution of the disease was 7.2 days, and 77.3 percent of the eyes had a detached macula at diagnosis. In 68.2 percent preoperative best corrected visual acuity was <20/200. Patients with a preoperative detached macula achieved a mean final visual acuity of 0.4 ± 0.3 (standard deviation). Good final anatomical and functional results were obtained in 86.4 percent and 77.3 percent of the eyes. Epiretinal membranes were a postoperative complication in both surgical techniques, whereas residual subretinal fluid was a complication only in neumatic retinopexy. Conclusions: Rhegmatogenous retinal detachment presents with poor preoperative visual acuity. Both surgical techniques obtain good anatomical and functional results in patients with minimum or no proliferative vitreoretinopathy(AU)

Cognitive-behavioral couple therapy for same-sex female couples: A pilot study.

Despite comparable levels of relationship satisfaction and intimacy, same-sex couples break up faster and more often than different-sex couples, highlighting a need for quality couple therapy. Research suggests that culturally tailored services are desired by same-sex couples and may be more effective and better received. Although efficacious couple therapies exist to treat relationship distress, they have been overwhelmingly studied with different-sex couples. Sexual minority (SM) affirming couple therapies have not been systematically developed or evaluated. The current study involved developing and pilot testing a couple therapy tailored for distressed same-sex female couples. This treatment integrates the SM stress model with the empirically supported cognitive-behavioral couple therapy framework and is the first culturally tailored couple therapy for same-sex couples to be empirically evaluated. Therapists delivered the treatment in an open-trial format to a pilot sample of 11 same-sex female couples experiencing relationship distress and SM stress. Treatment was delivered with high adherence to the treatment manual. Participants reported high treatment satisfaction. As hypothesized, participants experienced significant decreases in relationship distress and improvements in couple coping with SM stress from pre- to post-therapy. Limitations precluded clear conclusions regarding anticipated improvements in individual mental health. Participants experienced comparable or stronger improvements in relationship functioning compared to couples in a similar benchmark study. Given this is a small pilot study, results are interpreted with caution. Implications for culturally tailoring evidence-based couple therapy for marginalized groups are discussed.

A pesar de los niveles comparables de satisfacción con la relación y de intimidad, las parejas del mismo sexo se separan más rápidamente y con más frecuencia que las parejas de distinto sexo, lo cual destaca la necesidad de una terapia de pareja de calidad. Las investigaciones indican que las parejas del mismo sexo desean recibir servicios adaptados a las culturas, los cuales pueden ser más eficaces y mejor recibidos. Aunque existen terapias de pareja eficaces para tratar el distrés en las relaciones, estas se han estudiado en su mayoría con parejas de distinto sexo. Las terapias de pareja dedicadas a las minorías sexuales no se han desarrollado ni evaluado sistemáticamente. El presente estudio implicó el desarrollo y la prueba piloto de una terapia de pareja adaptada para parejas femeninas del mismo sexo con distrés. Este tratamiento integra el modelo de estrés de las minorías sexuales con el marco de la terapia de pareja cognitivo-conductual respaldado empíricamente, y es la primera terapia de pareja adaptada culturalmente para parejas del mismo sexo que se evalúa empíricamente. Los terapeutas administraron el tratamiento en un formato de estudio abierto a una muestra piloto de 11 parejas femeninas del mismo sexo que sufrían distrés relacional y estrés por minoría sexual. El tratamiento se aplicó con una alta adhesión al manual de tratamiento. Las participantes informaron una alta satisfacción con el tratamiento. Como se planteó en la hipótesis, las participantes disminuyeron considerablemente el distrés relacional y mejoraron en el afrontamiento del estrés por minoría sexual de la pareja después de la terapia respecto de antes de la terapia. Las limitaciones impidieron sacar conclusiones claras con respecto a la previsión de mejorías en la salud mental individual. Las participantes tuvieron mejorías comparables o más marcadas en el funcionamiento de la relación respecto de las parejas de un estudio comparativo similar. Teniendo en cuenta que este es un estudio piloto pequeño, los resultados se interpretan con cautela. Se comentan las implicancias para adaptar culturalmente la terapia de pareja factual para grupos marginados.

Ictus isquémico como forma de presentación de una disección aórtica tipo A / Type A aortic dissection presented as a stroke mimicker

Acute aortic dissection is a rare but lethal cardiac disease involving the aorta and it remains a challenge to diagnose and treat. The range of clinical features is extremely variable. Neurologic symptoms are also present in rare cases but often lead to a misdiagnosis because they mimic stroke. We report a case of a 71-year-old male with aortic dissection presented with acute onset altered mental status and left arm weakness. Aortic dissection presented with neurological symptoms is rare and requires high level of suspicion, especially in cases with unusual presentation. (AU)

Tratamiento coordinado entre centros de adicciones y salud mental vs. tratamiento no coordinado para pacientes con patología dual: mayor abandono, pero menor deterioro de la discapacidad funcional / Coordinated treatment between centres addiction and mental health centres vs. uncoordinated treatment for patients with dual pathology: greater dropout, but less deterioration of functional disability

Introducción: Los pacientes con patología dual son generalmente tratados en centros de salud mental y adicciones.Aunque hay servicios integrados para estos pacientes, lo máscomún es desarrollar protocolos de actuación conjunta entreestos centros. El objetivo de este estudio es analizar el progreso terapéutico de pacientes diagnosticados de patologíadual, comparando los resultados de pacientes atendidos enlos centros de adicciones exclusivamente, de salud mentalo bien atendidos de manera coordinada entre ambos servicios. La hipótesis es que los pacientes atendidos de maneracoordinada presentarán una mejor evolución en términos dela sintomatología psicopatológica, consumo de drogas y discapacidad funcional.Método. La muestra está formada por 182 pacientesatendidos en centros de adicción (n = 62), de salud mental (n= 51) y tratados a través del protocolo de actuación conjunta(n = 62). Los instrumentos administrados fueron la WHODAS2.0, BSI-18 y la SDSS.Resultados. No se encontraron diferencias estadísticamente significativas entre la evaluación basal y el seguimiento ni en la WHODAS 2.0 ni en el BSI-18. Se encontróun incremento del consumo de cocaína en los tres grupos,aunque fue estadísticamente significativa en los pacientesde adicciones y de salud mental. Hubo una mayor tasa deabandono del tratamiento en los pacientes atendidos de manera coordinada. En términos de cambio fiable, entre los pacientes atendidos de manera coordinada hubo más pacientesque mejoraron en la WHODAS 2.0.Conclusiones. Los hándicaps de asistir a dos redes asistenciales pueden estar explicando el mayor abandono de lospacientes que siguen el protocolo de actuación conjunta. Sinembargo, los pacientes que se mantienen en esta modalidadterapéutica muestran un menor deterioro de la funcionalidad en comparación con las otras dos modalidades. (AU)

Background: Dual pathology is often found in addictionand mental health centers. Although there are integratedservices for these patients, most countries have developedjoint action protocols between addiction and mental healthcenters. The objective is to analyze the progress of patientsdiagnosed with dual pathology, comparing the therapeuticoutcomes of those who exclusively attend either addictionor mental health centers with those patients who followa program in which the two services are coordinated. It ishypothesized that patients assisted in coordinate mannerwill present a better evolution on psychopathological symptomatology, drug use and functional impairment. Methods. The sample was 182 dual pathology patientstreated in addictions centers (n=62), mental health centers(n=51) and treated in a coordinated manner (n=62). The instruments administered was WHODAS 2.0, BSI-18 and SDSS.Results. In general, no statistically significant differences were found between baseline and follow up inWHODAS and BSI-18. More cocaine use was found inthree groups but was statistically significant in patientsattended by addictions center and mental health centers.High percentages of abandonment were found in patientsattending coordinate services. In terms of reliable change, among those receiving the coordinated treatment,there were more patients who showed improvements inthe WHODAS 2.0 dimensions.Conclusions. The inconvenience caused by going to different treatment networks may partially explain these resultsrelated with abandonment. However, patients who remain intreatment in coordinated services, show lower functionalitydeterioration than patients in other modalities. (AU)

Evidencia basada en la práctica en psicoterapia: el reto en Latinoamérica / Practice-based evidence in psychotherapy: the challenge in Latin America

Resumen El artículo presenta una revisión teórica sobre el paradigma de la Práctica Basada en la Evidencia y sobre el de la Evidencia Basada en la Práctica en el ámbito de la psicoterapia; se profundiza especialmente en este último paradigma y su asociación con la investigación de la efectividad en psicoterapia. Posteriormente, se contextualiza el funcionamiento de este último paradigma en los sistemas de salud y en particular en la atención en salud mental, haciendo hincapié en su aplicabilidad en la evaluación rutinaria y su potencial para contribuir al campo de la investigación en psicoterapia. Finalmente, se presentan algunas conclusiones sobre cómo promover la investigación orientada a la Evidencia Basada en la Práctica en contextos psicoterapéuticos, a partir de Redes de Investigación en la Práctica en los países latinoamericanos.

Abstract This article presents a theoretical review of the Evidence-Based Practice and the Practice-Based Evidence in psychotherapy, the latter is explained in depth considering its association with the research of the effectiveness in psychotherapy. Subsequently, the functioning of this last paradigm in health systems, particularly in mental health care is contextualized, emphasizing its applicability in routine evaluation and its potential to contribute to the field of research in psychotherapy. Finally, some conclusions are presented on how to promote research based on the paradigm of Practice-Based Evidence in psychotherapeutic contexts, based on Practice Research Networks in Latin American countries.

[Common mental disorders in primary care: diagnostic and therapeutic difficulties, and new challenges in prediction and prevention. SESPAS Report 2020]. / Enfermedades mentales comunes en atención primaria: dificultades diagnósticas y terapéuticas, y nuevos retos en predicción y prevención. Informe SESPAS 2020.

In primary health care only chronic pain surpass depression and anxiety in loss of quality-adjusted life years. More than 70% of people suffering from common mental disorders consulted their GPs for this reason. However, 'the declining halves rule' is a reality: less than 50% of primary care attendees with common mental disorders were correctly diagnosed, of these less than 50% received adequate treatment (pharmacological or psychological) and of these less than 50% patients were adherent. Collaborative models of common mental disorders care in primary health care have demonstrated their effectiveness through clinical trials; however, its implementation in a more general and real context is difficult and its effectiveness remains unclear. Risk algorithms have been developed and validated in primary health care to predict the onset and prognosis of common mental disorders; which are useful for their treatment and prevention. There is evidence that psychological and psychoeducational interventions (and possibly those of physical exercise) are effective for the primary prevention of common mental disorders, even in primary health care; although their effects are small or moderate. These interventions have a high potential to be scalable in schools, workplace and primary health care; in addition, when they are administered through information and communication technologies (e.g. by App), in self-guided or minimally guided programs, they have demonstrated their effectiveness for the treatment and prevention of common mental disorders. They are also very accessible, have low cost and contribute to the massive implementation of these interventions in different settings.

Follow-up in head and neck cancer. What the radiologist must know. / Seguimiento del cáncer de cabeza y cuello tratado. Lo que el radiólogo debe conocer.

The management of patients with head and neck cancer implies a multidisciplinary treatment with surgery, radiotherapy and chemotherapy. Imaging is crucial in their follow-up, especially when the tumor recurrence is not clinically evident. Radiologically distinguishing post-treatment changes from a tumor recurrence is a challenge due to the anatomical alteration due to surgical techniques and their reconstructions, radiotherapy treatment and chemotherapeutic guidelines. The differential diagnosis must include the possible complications derived from radiotherapy (mucosal necrosis, osteoradionecrosis, vasculopathy, cerebral radionecrosis) and surgery (wound infections, flap necrosis, fistulas,...). A wide knowledge of the expected findings of multimodal treatment and its complications is essential for an accurate diagnosis of tumor recurrence. Finally, choosing the appropriate image study and having a baseline post-treatment study is also relevant for a suitable radiological control.

Tasa libre de litos sin complicación mayor como definición de éxito en nefrolitotomía percutánea / Stone-free rate without major complication as a definition of success in percutaneous nephrolithotomy

Resumen Introducción: El éxito en nefrolitotomía percutánea (NLP) se define como estatus libre de litos, sin embargo, las complicaciones mayores se presentan con alta frecuencia y han sido reportadas como resultado secundario. Objetivo: Presentar una nueva definición de éxito en NLP que comprenda la tasa libre de litos sin complicaciones mayores y una escala de riesgo para predecir este desenlace. Método: Cohorte histórica de pacientes sometidos a NLP. Las variables incluidas fueron edad, sexo, urocultivo, índice de comorbilidad de Charlson (ICC) y lito complejo. Se definió éxito: sin litos, sin o con complicación Clavien ≤ 2; éxito intermedio: con litos sin o con complicación Clavien ≤ 2; fracaso: con o sin litos con complicación Clavien > 2. Se realizó análisis bivariado para identificar los factores asociados con el desenlace. Por regresión logística múltiple se calculó el peso independiente de cada factor. Resultados: Se incluyeron 568 procedimientos, 59 % en el sexo femenino. La mediana de edad fue de 49 años; 65, 22 y 13 % de los casos tuvieron éxito, éxito intermedio y fracaso. El sexo femenino, urocultivo positivo, lito complejo e ICC severo se asociaron con fracaso. Conclusión: La probabilidad de éxito fue directamente proporcional al número de factores de riesgo.

Abstract Introduction: Success in percutaneous nephrolithotomy (PCNL) is defined as a stone-free status; however, major complications are highly common and have been reported as a secondary outcome. Objective: To propose a new definition of PCNL success that comprises a stone free rate without major complications and a risk scale to predict this outcome. Methods: Historical cohort of patients undergoing PCNL. The included variables were age, gender, urine culture, Charlson's comorbidity index (CCI) and complex stones. Success was defined as a stone free status with or without Clavien grade ≤ 2 complication; intermediate success: with stones, with or without Clavien grade ≤ 2 complication; and failure: with or without stones with Clavien grade ≤ 2 complication. Bivariate analysis was performed to identify which factors are associated with the outcome. The independent weight of each factor was calculated by multiple logistic regression analysis. Results: 568 procedures were included, 59% of which were in females. Median age was 49 years; 65%, 22% and 13% of cases were classified as success, intermediate success and failure, respectively. Female sex, positive urine culture, complex stones and severe CCI were associated with failure. Conclusions: The likelihood of success was directly proportional to the number of risk factors.

Audit of cataract surgery in Cadiz: visual outcomes and complications. / Auditoría de la cirugía de catarata senil en Cádiz: resultados visuales y complicaciones.

OBJECTIVE: To publish the outcomes and complications of age-related cataract surgery in Cadiz (Spain). Due to the lack of national audits, a comparison was made between the results obtained here and those of the most recent European audit, EUREQUO (2013), and the British audit RCOphth NOD (2015). METHODS: A prospective, longitudinal, before-after study of 312 patients undergoing cataract surgery in the University Hospitals of Puerta del Mar and Puerto Real (Cadiz), in 2013-14. Outcome measurements included sociodemographic characteristics, visual acuity (VA), symptoms secondary to cataract, ocular comorbidity, waiting time, expertise of surgeon (consultant vs. trainee), rate and type of surgical complications. RESULTS: The median age at surgery was 73.92±7.31. Almost all (98.3%) of patients at consultation had a VA ≥0.60logMAR, with a mean pre-surgical VA of 1.01logMAR (0.92-1.10). There was a 6.7% complication rate, with 3.8% posterior capsule ruptures and 2.8% corneal decompensations. No cases of endophthalmitis occurred. The mean post-operative VA was 0.28logMAR (0.22-0.33). More than three-quarters (78.8%) of cases achieved a post-operative VA ≤0.3logMAR, and 27.6% of cases achieved a VA ≤0.0logMAR. CONCLUSIONS: Our success rate was inferior to the EUREQUO and RCOphth NOD studies, with the percentage of patients acquiring a postoperative VA ≤0.3logMAR being 98% and 89%, respectively. However, the populations were not comparable. It is hoped that this study will encourage other public hospitals in Spain to undertake audits and share their results, in order to provide a tool for constructive criticism and quality improvement initiatives.

We-Language and Sustained Reductions in Drinking in Couple-Based Treatment for Alcohol Use Disorders.

Couple-based treatments for alcohol use disorders (AUDs) produce higher rates of abstinence than individual-based treatments and posit that active involvement of both identified patients (IPs) and significant others (SOs) is partly responsible for these improvements. Separate research on couples' communication has suggested that pronoun usage can indicate a communal approach to coping with health-related problems. The present study tested whether communal coping, indicated by use of more first-person plural pronouns ("we" language), fewer second-person pronouns ("you" language), and fewer first-person singular pronouns ("I" language), predicted improvements in abstinence in couple-based AUD treatment. Pronoun use was measured in first- and mid-treatment sessions for 188 heterosexual couples in four clinical trials of alcohol behavioral couple therapy (ABCT). Percentages of days abstinent were assessed during treatment and over a 6-month follow-up period. Greater IP and SO "we" language during both sessions was correlated with greater improvement in abstinent days during treatment. Greater SO "we" language during first- and mid-treatment sessions was correlated with greater improvement in abstinence at follow-up. Greater use of IP and SO "you" and "I" language had mixed correlations with abstinence, typically being unrelated to or predicting less improvement in abstinence. When all pronoun variables were entered into regression models, only greater IP "we" langue and lower IP "you" language predicted improvements in abstinence during treatment, and only SO "we" language predicted improvements during follow-up. Most pronoun categories had little or no association with baseline relationship distress. Results suggest that communal coping predicts better abstinence outcomes in couple-based AUD treatment.

IBC: índice Board CES / The IBC: CES Board Index

Resumen La medición de resultados de los tratamientos de ortodoncia es fundamental para evaluar objetivamente la calidad de la finalización y el éxito logrado por la terapia, y a su vez en la evaluación de los residentes del posgrado de ortodoncia. En la literatura se han reportado varios sistemas que permiten analizar dichos resultados, pero algunos no integran suficientes criterios o ayudas diagnósticas. La Universidad CES, basada en el American Board of Orthodontics-Objetctive Grading System (ABO-OGS), ha desarrollado un índice con 16 criterios analizados en modelos, radiografías y fotografías, que integran una medición objetiva de la finalización de los tratamientos. El propósito de este artículo fue describir el índice Board CES (IBC) como herramienta de evaluación de resultados clínicos de la ortodoncia y generar retroalimentación para el tratamiento de casos futuros mejorando la calidad de los mismos. Dicho índice podría ser empleado en universidades y en prácticas privadas.

The measurement of orthodontic treatment results is crucial to objectively assess the quality of the completion and success of therapy, and in turn in the evaluation of graduate orthodontic residents. The literature has reported several systems that analyze these results, but some do not integrate sufficient criteria or diagnostic aids. CES University, based on the American Board of Orthodontics - Objective Grading System (ABO - OGS), has developed an index with 16 criteria analyzed in models, radiographs and photographs, which allow an objective measurement of the completion of treatments. The purpose of this article was to describe the CES Board Index (IBC) as a tool for assessing clinical outcomes in orthodontics and generate feedback for the treatment of future cases improving their quality. This index could be used in Universities and in private practices.

Evaluación preliminar de un programa para parejas no casadas que han presentado malos tratos / Preliminary evaluation of a program for unmarried couples that have presented abuse

El objetivo de esta investigación fue efectuar una evaluación preliminar de un programa de tratamiento dirigido a parejas jóvenes no casadas que han presentado malos tratos en su relación, el cual contemplaba el mejoramiento de las habilidades de comunicación, empatía y manejo de la ira, entre otros componentes implementados desde el enfoque de terapia y modificación del comportamiento. Se utilizó un diseño pretest-postest de un solo grupo, con la participación de cuatro parejas heterosexuales entre 17 y 22 años de edad (X = 20 años; DX = 1,89 años). Los efectos se evaluaron a través del STAXI II, el ASPA (Cuestionario de Aserción en la Pareja), una escala de actitudes hacia la violencia íntima, un cuestionario de satisfacción con el programa y una lista de chequeo de experiencias de maltrato en la pareja. Los resultados evidenciaron decrementos postratamiento significativos en la frecuencia de malos tratos, en la ira como estado y en las actitudes hacia la violencia, así como una buena satisfacción con el programa. Se proponen ajustes en los contenidos del mismo, de cara a la realización de un ensayo clínico controlado.

The objective of this research was to conduct a preliminary evaluation of a treatment aimed at unmarried young couples who have had abuse in their relationship. The program included improving communication skills, empathy and anger management, among other components, under a behavior therapy perspective. A pretest-posttest one-group design was used, with the participation of four heterosexual couples between 17 and 22 years (X=20 years, DX=1.89 years). The effects were evaluated through the staxi ii, the Assertion Questionnaire in the Couple, a scale of attitudes toward intimate violence, a program satisfaction questionnaire, and a checklist of experiences of partner abuse. The results showed significant post-treatment decreases on the frequency of abuse, attitudes toward intimate violence, and anger as a state, and a good satisfaction with the program. Adjustments in the contents of the program for the achievement of a controlled clinical trial are proposed.

Dipirona: ¿Beneficios subestimados o riesgos sobredimensionados? Revisión de la literatura / Dipyrone: Benefits underestimated or oversized risks? Review of the literature.

Dipirona es un analgésico, antipirético, espasmolítico y antiinflamatorio de amplio uso en Colombia y Latinoamérica, proscrito por agencias regulatorias de referencia, por el riesgo de agranulocitosis y otras discrasias sanguíneas. Estos antecedentes han generado controversia e incluso aprensión dentro de los prescriptores, lo cual justifica esta revisión. Una vez revisada la literatura se encuentra que dipirona es eficaz como antipirético y para manejo del dolor agudo, crónico, postoperatorio, cólico renal y migraña. La prevalencia de agranulocitosis es de 0,03 al 0,5% en pacientes europeos y la incidencia de pacientes hispanos está alrededor de 0,38 casos por un millón de habitantes/año y aun menor en anemia aplásica. El riesgo de lesión gástrica es menor que el de otros AINEs de uso habitual y es un medicamento relativamente seguro en el embarazo. Otros efectos adversos incluyen hipersensibilidad, anafilaxia, pénfigo e hipotensión arterial relacionada con la administración intravenosa rápida del medicamento. Conclusiones: Dipirona conlleva un riesgo muy bajo de generar discrasias sanguíneas en población latinoamericana posiblemente por factores farmacogenéticos aún no identificados. Los principales factores de riesgo incluyen la duración del tratamiento, la dosis empleada y el uso concomitante de otros medicamentos que generen mielotoxicidad.

Dipyrone is an analgesic, antipyretic, antispasmodic and anti-inflammatory widely used in Colombia and Latin America, outlawed by reference regulatory agencies due to the risk of agranulocytosis and other blood dyscrasias. These facts have generated controversy and even apprehension within prescribers, which justifies this review. After reviewing the literature is that dipyrone is effective as antipyretic and management of acute pain, chronic, postoperative, renal colic and migraine. The prevalence of agranulocytosis is 0.03 to 0.5% in European patients and the incidence in Hispanic patients is about 0.38 cases per million inhabitants / year and even lower for aplastic anemia. Gastric injury risk is lower than that of other commonly used NSAIDs and is a relatively safe drug during pregnancy. Other adverse effects include hypersensitivity, anaphylaxis, pemphigus and hypotension related to rapid intravenous administration of the drug. Conclusions: Dipyrone carries a very low risk of blood dyscrasias in Latin American population, possibly due to pharmacogenetic factors not yet identified. The main risk factors include duration of treatment, the dose used and the concomitant use of other drugs that produce myelotoxicity.